Clinical Trial Update: Combination Chemotherapy With CS-1008 to Treat Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of CS-1008 in combination chemotherapy for ovarian cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CS-1008

Snippet

Sponsor: Daiichi Sankyo | Conditions: Ovarian Cancer Stage IIIC, Ovarian Cancer Stage IV | Phase 2 | Status: COMPLETED | Results posted: 2020-11-18